Dr. Daneshmand on Blue Light Cystoscopy for Bladder Cancer

Siamak Daneshmand, MD
Published: Friday, May 26, 2017


 Siamak Daneshmand, MD, associate professor of Urology, Director of Clinical Research, Keck School of Medicine of USC, discusses blue light cystoscopy compared with white light cystoscopy for patients with bladder cancer.

This phase III study involved 304 patients at 17 leading institutions in the United States, explains Daneshmand. The objective was to determine if blue light cystoscopy increased the detection of bladder tumors.

Patients first underwent white light cystoscopy and then would have blue light cystoscopy done, states Daneschmand. The number and character of lesions were determined and compared with the number seen in the operating room.


 Siamak Daneshmand, MD, associate professor of Urology, Director of Clinical Research, Keck School of Medicine of USC, discusses blue light cystoscopy compared with white light cystoscopy for patients with bladder cancer.

This phase III study involved 304 patients at 17 leading institutions in the United States, explains Daneshmand. The objective was to determine if blue light cystoscopy increased the detection of bladder tumors.

Patients first underwent white light cystoscopy and then would have blue light cystoscopy done, states Daneschmand. The number and character of lesions were determined and compared with the number seen in the operating room.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Oncology Best Practice™ Decision Points in Advanced NSCLC: Assessing Treatment Options Beyond Disease ProgressionNov 30, 20181.0
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x